U.S. flag

An official website of the United States government

NM_020822.3(KCNT1):c.1283G>A (p.Arg428Gln) AND Developmental and epileptic encephalopathy, 14

Germline classification:
Pathogenic (6 submissions)
Last evaluated:
May 20, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000032793.18

Allele description [Variation Report for NM_020822.3(KCNT1):c.1283G>A (p.Arg428Gln)]

NM_020822.3(KCNT1):c.1283G>A (p.Arg428Gln)

Gene:
KCNT1:potassium sodium-activated channel subfamily T member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.3
Genomic location:
Preferred name:
NM_020822.3(KCNT1):c.1283G>A (p.Arg428Gln)
HGVS:
  • NC_000009.12:g.135765706G>A
  • NG_033070.1:g.68522G>A
  • NM_001272003.2:c.1148G>A
  • NM_020822.3:c.1283G>AMANE SELECT
  • NP_001258932.1:p.Arg383Gln
  • NP_065873.2:p.Arg428Gln
  • NC_000009.11:g.138657552G>A
  • NM_020822.2:c.1283G>A
Protein change:
R383Q; ARG428GLN
Links:
OMIM: 608167.0001
Molecular consequence:
  • NM_001272003.2:c.1148G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020822.3:c.1283G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Name:
Developmental and epileptic encephalopathy, 14 (DEE14)
Synonyms:
Early infantile epileptic encephalopathy 14
Identifiers:
MONDO: MONDO:0013989; MedGen: C3554195; Orphanet: 293181; OMIM: 614959

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000056561OMIM
no assertion criteria provided
Pathogenic
(Nov 1, 2012)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001150141Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
criteria provided, single submitter

(Classification criteria August 2017)
Pathogenic
(Apr 3, 2018)
de novoclinical testing

Citation Link,

SCV001164183Génétique des Maladies du Développement, Hospices Civils de Lyon
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 29, 2018)
de novoclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001815797New York Genome Center - CSER-NYCKidSeq
criteria provided, single submitter

(NYGC Assertion Criteria 2020)
Pathogenic
(Sep 19, 2020)
germlineclinical testing

Citation Link,

SCV003921940Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 2, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV004048534Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 20, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedde novoyes1not providednot provided1not providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.

Barcia G, Fleming MR, Deligniere A, Gazula VR, Brown MR, Langouet M, Chen H, Kronengold J, Abhyankar A, Cilio R, Nitschke P, Kaminska A, Boddaert N, Casanova JL, Desguerre I, Munnich A, Dulac O, Kaczmarek LK, Colleaux L, Nabbout R.

Nat Genet. 2012 Nov;44(11):1255-9. doi: 10.1038/ng.2441. Epub 2012 Oct 21.

PubMed [citation]
PMID:
23086397
PMCID:
PMC3687547

Targeted treatment of migrating partial seizures of infancy with quinidine.

Bearden D, Strong A, Ehnot J, DiGiovine M, Dlugos D, Goldberg EM.

Ann Neurol. 2014 Sep;76(3):457-61. doi: 10.1002/ana.24229. Epub 2014 Jul 26.

PubMed [citation]
PMID:
25042079
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000056561.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 3 unrelated patients (patients 2, 3, and 4) of French origin with developmental and epileptic encephalopathy-14 (DEE14; 614959) manifest clinically as malignant migrating partial seizures of infancy (MMPSI), Barcia et al. (2012) identified a de novo heterozygous 1283G-A transition in exon 13 of the KCNT1 gene, resulting in an arg428-to-gln (R428Q) substitution at a highly conserved residue in the cytoplasmic C-terminal domain. The mutation was initially identified by exome sequencing and confirmed by Sanger sequencing in 1 patient; analysis of this gene in subsequent patients identified the same mutation in 2 other individuals with the same disorder. The mutation was not found in 200 controls or in several large control databases. Expression of the corresponding rat mutation, R409Q, in Xenopus oocytes resulted in Kcnt1-generated currents that resembled wildtype in terms of voltage dependence and kinetic behavior but had 2- to 3-fold higher amplitude compared to wildtype, consistent with a gain of function. The mutation was shown to cause constitutive activation of the Kcnt1 channel, mimicking the effects of phosphorylation of the C-terminal domain by protein kinase C (see, e.g., PRKCA, 176960) activation. The patients had onset of seizures at 2 hours, 17 hours, and 2 months of age, respectively.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München, SCV001150141.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyes1bloodnot provided1not providednot providednot provided

From Génétique des Maladies du Développement, Hospices Civils de Lyon, SCV001164183.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

From New York Genome Center - CSER-NYCKidSeq, SCV001815797.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The heterozygous c.1283G>A (p.Arg428Gln) variant identified in the KCNT1 gene substitutes a well conserved Arginine for Glutamine at amino acid 428/1236 (coding exon 13/31). This variant is absent from gnomAD(v3.0) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict this variant to be Deleterious (Provean; score:-3.81) and Damaging (SIFT; score:0.003) tothe function of the canonical transcript. This variant is reported as Pathogenic in ClinVar (VarID:39593), and has been reported in many affected individuals in the literature [PMID:31872048, 23086397,31653631, 31208268, 30234941, others]. Functional studies suggest this variant leads to constitutive activation of the of the potassium channel [PMID:23086397, 24591078]. Given its absence in population databases, in silico predictions of a damaging effect, functional studies supporting pathogenicity, and its observation in many affected individuals in the literature, the c.1283G>A (p.Arg428Gln) variant identified in the KCNT1 gene is reported as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV003921940.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with developmental and epileptic encephalopathy 14 (MIM#614959). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 26740507). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glutamine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2: 3 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0801 - This variant has very strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by clinical laboratories in ClinVar and observed in four unrelated individuals with malignant migrating partial seizures of infancy (MMPSI) (ClinVar, PMID: 23086397, 25042079). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV004048534.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The observed missense c.1283G>A(p.Arg428Gln) variant in KCNT1 gene has been reported in heterozygous state in individuals affected with KCNT1 related diseases (Alsaleem M, et. al., 2019; Barcia G, et. al., 2019; Datta AN, et. al., 2019). Experimental studies have shown that this missense change affects KCNT1 function (Milligan CJ, et. al., 2014; Barcia G, et.al., 2012). The p.Arg428Gln variant is absent in gnomAD Exomes database. This variant has been reported to the ClinVar database as Pathogenic (multiple submissions). Multiple lines of computational evidence (Polyphen - probably damaging, SIFT - damaging and MutationTaster - disease causing) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg428Gln in KCNT1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 428 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024